CN108294961A - A kind of lyase formula and its application in Skin Cell activation - Google Patents
A kind of lyase formula and its application in Skin Cell activation Download PDFInfo
- Publication number
- CN108294961A CN108294961A CN201810173900.4A CN201810173900A CN108294961A CN 108294961 A CN108294961 A CN 108294961A CN 201810173900 A CN201810173900 A CN 201810173900A CN 108294961 A CN108294961 A CN 108294961A
- Authority
- CN
- China
- Prior art keywords
- lyase
- skin
- formula
- parts
- niacinamide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
- A61K33/10—Carbonates; Bicarbonates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/673—Vitamin B group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Birds (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention discloses a kind of lyase formulas, include the component of following parts by weight：10 40 parts of 10 40 parts of D calcium carbonate and niacinamide.Application of the lyase formula in Skin Cell activation, for repairing the skin damaged after laser therapy.Lyase formula using the present invention stimulates cytothesis, increases cuticle thickness, is enhanced by cell activity, rapid metabolization, by skin surface damaged cell, including pigment, reparation and is metabolized, market verification in 3 years is without an example allergy.Allergic skin is used and is also had no adverse reaction.
Description
Technical field
The present invention relates to medical skin treatment field, specifically a kind of lyase formula and its answering in Skin Cell activation
With.
Background technology
Laser beautifying is a kind of new face-beautifying method risen in recent years.Laser is more and more extensive in the purposes of beauty circle.Swash
Just by generating high-energy, focus accurate, the monochromatic light with certain penetration power, act on tissue and in local generation
High heat is to achieve the purpose that removal or destroy destination organization.
The principle of micropin beauty is to stimulate skin using many small syringe needles on micropin idler wheel, micro- within a very short time
Needle can be made more than millions of a microtubules, and active constituent is enabled effectively to penetrate into skin, be equipped with anti-wrinkle, whitening, repair, dispel it is pregnant
It is pregnent the special efficacys product such as line, scar eliminating, subtracts light wrinkle to reach, treatment scar and striae of pregnancy, skin whitening, subtracts light color spot, changes
The ideal effects such as kind eye wrinkle-removing, livid ring around eye, tightening and promotion skin of face tissue.Micropin stimulates skin corium simultaneously, passes through skin
The self-healing ability of skin promotes ossein hyperplasia, can make the thickness hyperplasia about 8 percent of skin epidermis, effect can match in excellence or beauty sharp
The plastic operation of light and filled type.
Laser, micropin are all the prior arts, skin has damage after laser, therefore a kind of be used cooperatively is needed during treating
The lyase formula of epidermal growth factor.
Invention content
A kind of application the purpose of the present invention is to provide lyase formula and its in Skin Cell activation, it is above-mentioned to solve
The problem of being proposed in background technology.
To achieve the above object, the present invention provides the following technical solutions：
A kind of lyase formula, includes the component of following parts by weight：10-40 parts of 10-40 parts of D- calcium carbonate and niacinamide.
As further scheme of the invention：The lyase formula includes the component of following parts by weight：D- calcium carbonate 10
40 parts of part and niacinamide.
As further scheme of the invention：The lyase formula includes the component of following parts by weight：D- calcium carbonate 25
25 parts of part and niacinamide.
As further scheme of the invention：The lyase formula includes the component of following parts by weight：D- calcium carbonate 40
10 parts of part and niacinamide.
As further scheme of the invention：Application of the lyase formula in Skin Cell activation.
As further scheme of the invention：For repairing the skin damaged after laser therapy.
Niacinamide：Niacinamide is a kind of water soluble vitamin and is a member in vitamin B complex.It is mainly used for preventing rough skin
And stomatitis, glossitis etc..Vitamin drug participates in internal metabolic process, for preventing the pellagra such as pellagra.
D-VB5 calcium：White or yellowish crystalline powder.It is odorless.Sweet then slightly bitter taste.As feed addictive, food
Product additive and medicine.
Compared with prior art, the beneficial effects of the invention are as follows：Lyase formula using the present invention stimulates cytothesis, increases
Add cuticle thickness, is enhanced by cell activity, rapid metabolization, by skin surface damaged cell, including pigment, reparation and generation
It thanks, market verification in 3 years is without an example allergy.Allergic skin is used and is also had no adverse reaction.
Specific implementation mode
Below in conjunction with the embodiment of the present invention, technical scheme in the embodiment of the invention is clearly and completely described,
Obviously, described embodiments are only a part of the embodiments of the present invention, instead of all the embodiments.Based in the present invention
Embodiment, every other embodiment obtained by those of ordinary skill in the art without making creative efforts, all
Belong to the scope of protection of the invention.
Embodiment 1
In the embodiment of the present invention, a kind of lyase formula includes the component of following parts by weight：10 parts of D- calcium carbonate and niacinamide
10 parts.
Embodiment 2
In the embodiment of the present invention, a kind of lyase formula includes the component of following parts by weight：10 parts of D- calcium carbonate and niacinamide
40 parts.
Embodiment 3
In the embodiment of the present invention, a kind of lyase formula includes the component of following parts by weight：25 parts of D- calcium carbonate and niacinamide
25 parts.
Embodiment 4
In the embodiment of the present invention, a kind of lyase formula includes the component of following parts by weight：40 parts of D- calcium carbonate and niacinamide
10 parts.
Embodiment 5
In the embodiment of the present invention, a kind of lyase formula includes the component of following parts by weight：40 parts of D- calcium carbonate and niacinamide
40 parts.
Application of the lyase formula in Skin Cell activation described in embodiment 1-5, lyase formula of the invention is for repairing
The skin damaged after compounding light treatment solves to lead to the red blood silk of the skin sensitivity and cuticle loss that occur because of cuticle loss
Leakage, auxiliary treatment nodositas small pox, acne print, acne hole.
After the lyase formula is divided into microneedle theraphy and treats, application method is：
First, treated for skin problem using intense pulsed light (need according to different skin quality, the type of pigment,
Small pox, acne print degree select the wavelength of different pulsed lights, pulse strength)；
Then, micropin cooperation epidermal growth factor is used to carry out cuticula reparation after a week, micropin uses lyase formula.
Lyase formula using the present invention stimulates cytothesis, increases cuticle thickness, is enhanced by cell activity, rapidly
Metabolism by skin surface damaged cell, including pigment, reparation and is metabolized, and market verification in 3 years is without an example allergy.Allergic skin
Using also having no adverse reaction.
It is obvious to a person skilled in the art that invention is not limited to the details of the above exemplary embodiments, Er Qie
In the case of without departing substantially from spirit or essential attributes of the invention, the present invention can be realized in other specific forms.Therefore, no matter
From the point of view of which point, the present embodiments are to be considered as illustrative and not restrictive, and the scope of the present invention is by appended power
Profit requires rather than above description limits, it is intended that all by what is fallen within the meaning and scope of the equivalent requirements of the claims
Variation is included within the present invention.
In addition, it should be understood that although this specification is described in terms of embodiments, but not each embodiment is only wrapped
Containing an independent technical solution, this description of the specification is merely for the sake of clarity, and those skilled in the art should
It considers the specification as a whole, the technical solutions in the various embodiments may also be suitably combined, forms those skilled in the art
The other embodiment being appreciated that.
Claims (6)
1. a kind of lyase formula, which is characterized in that include the component of following parts by weight：10-40 parts of D- calcium carbonate and niacinamide 10-
40 parts.
2. lyase formula according to claim 1, which is characterized in that include the component of following parts by weight：D- calcium carbonate 10
40 parts of part and niacinamide.
3. lyase formula according to claim 1, which is characterized in that include the component of following parts by weight：D- calcium carbonate 25
25 parts of part and niacinamide.
4. lyase formula according to claim 1, which is characterized in that include the component of following parts by weight：D- calcium carbonate 40
10 parts of part and niacinamide.
5. a kind of application of lyase formula as described in claim 1-4 is any in Skin Cell activation.
6. application of the lyase formula according to claim 5 in Skin Cell activation, which is characterized in that sharp for repairing
The skin damaged after light treatment.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201810173900.4A CN108294961A (en) | 2018-03-02 | 2018-03-02 | A kind of lyase formula and its application in Skin Cell activation |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201810173900.4A CN108294961A (en) | 2018-03-02 | 2018-03-02 | A kind of lyase formula and its application in Skin Cell activation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN108294961A true CN108294961A (en) | 2018-07-20 |
Family
ID=62849205
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201810173900.4A Pending CN108294961A (en) | 2018-03-02 | 2018-03-02 | A kind of lyase formula and its application in Skin Cell activation |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN108294961A (en) |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106726686A (en) * | 2017-01-19 | 2017-05-31 | 弎西艾斯（苏州）生物科技有限公司 | A kind of human skin cell's growth-promoting media |
| CN108042461A (en) * | 2018-01-25 | 2018-05-18 | 丛硕 | A kind of moisturizing maintenance Essence |
-
2018
- 2018-03-02 CN CN201810173900.4A patent/CN108294961A/en active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106726686A (en) * | 2017-01-19 | 2017-05-31 | 弎西艾斯（苏州）生物科技有限公司 | A kind of human skin cell's growth-promoting media |
| CN108042461A (en) * | 2018-01-25 | 2018-05-18 | 丛硕 | A kind of moisturizing maintenance Essence |
Non-Patent Citations (2)
| Title |
|---|
| 余辉等: "烟酰胺在皮肤科的应用进展", 《国际皮肤性病学杂志》 * |
| 周糯玉等: "d-泛酸钙的用途、市场与生产", 《现代化工》 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Chan et al. | Characteristics and management of Asian skin | |
| Vrcek et al. | Infraorbital dark circles: a review of the pathogenesis, evaluation and treatment | |
| Mamalis et al. | Laser and light‐based treatment of Keloids–a review | |
| Friedmann et al. | Combination of intense pulsed light, Sculptra, and Ultherapy for treatment of the aging face. | |
| Savas et al. | Pulsed dye laser‐resistant port‐wine stains: mechanisms of resistance and implications for treatment | |
| Butterwick et al. | Hand rejuvenation using a combination approach | |
| Cannarozzo et al. | Deep pulse fractional CO2 laser combined with a radiofrequency system: results of a case series | |
| US9504847B2 (en) | Method for performing phototherapy | |
| US20150140114A1 (en) | Skin treatment protocol utilizing amniotic solution | |
| Zhang et al. | Improvement of surgical scars by early intervention with carbon dioxide fractional laser | |
| Sieber et al. | Noninvasive methods for lower facial rejuvenation | |
| Peterson et al. | Three-dimensional rejuvenation of the décolletage | |
| Dell’Avanzato | Endolift®: the “lunch-time” laser lifting for the lower eyelids | |
| CN108294961A (en) | A kind of lyase formula and its application in Skin Cell activation | |
| Briceño et al. | Minimally invasive options for the brow and upper lid | |
| Kozarev | Use of long pulse Nd: YAG 1064 nm laser for treatment of rosacea Telangiectatica | |
| Goodman | Blood transfer: the use of autologous blood as a chromophore and tissue augmentation agent | |
| Karsai et al. | Abstract | |
| CN106975158A (en) | A kind of beauty instrument and the method that beautifying skin is carried out using the beauty instrument | |
| Ding et al. | Application of integrated skincare in medical aesthetics: A literature review | |
| KR101666838B1 (en) | Scar treatment Systems | |
| Wong et al. | Reply: The Long-Term Static and Dynamic Effects of Surgical Release of the Tear Trough Ligament and Origins of the Orbicularis Oculi in Lower Eyelid Blepharoplasty | |
| RU2611946C1 (en) | Apparatus for laser biorevitalization of skin on face, neck and body | |
| Winocour et al. | Venous thromboembolism in the cosmetic patient | |
| Vascularity | Treatment of Periorbital |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20180720 |
|
| WD01 | Invention patent application deemed withdrawn after publication |